-
Forward Look
Addressing Depression in Adult Cancer SurvivorsStudy links depression to money woes and missed opportunities for follow-up.
by Marilyn Fenichel
-
Forward Look
Report Links Excess Weight to Eight More Cancer TypesReview increases number from five to 13.
by Kendall K. Morgan
-
Forward Look
Little Consensus on Ovarian Cancer MonitoringTests and scans may be overused.
by Kate Yandell
-
Forward Look
No Link Found Between IVF and Breast Cancer RiskStudy findings will reassure many families.
by Cameron Walker
-
Screening Gets Personal
Conflicting and changing cancer screening guidelines have led to uncertainty and controversy. Can screening recommendations tailored for groups or individuals enhance benefits and reduce harms?
by Kate Yandell
-
Making a Match
Oncologists and researchers are looking for new drug combinations that extend patient survival without worsening side effects, but it's a daunting task.
by Stephen Ornes
-
Healthy Habits
Reaping Grains’ BenefitsStudies point to a reduced risk of cancer death from eating whole grains, but questions remain.
by Brenda Conaway
-
Healthy Habits
Put a Cork in ItDrinking alcohol increases the risk for at least seven types of cancer.
by Brenda Conaway
-
From the Editor-in-Chief
Cancer and the MicrobiomeAltering the gut microbiota and microbiome could become a strategy for cancer prevention and treatment.
by William G. Nelson, MD, PhD
-
Forward Look
What Is CRISPR?Q&A with oncologist Howard Kaufman on the new gene-editing tool.
by Chris Palmer
Cancer Talk
Living With Your Loved One’s Prostate Cancer
Christine Ledbetter on the ways her husband’s prostate cancer affected their relationship and finding support as a caregiver.
by Christine Ledbetter
Continuing the ConversationThe AACR hosts a roundtable to ‘get real’ about cancer health disparities.
by Marci A. Landsmann
More Patients Participating in Cancer ResearchA higher proportion of cancer patients are enrolling in research studies than previously thought, but many patients lack the access needed to participate.
by Kyle Bagenstose
Immunotherapy Drug Tarlatamab Approved for Advanced Small Cell Lung CancerThe drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.
by Laura Gesualdi-Gilmore